Stock Analiz

Fitlife Brands, Inc. FTLF

Medicinal Chemicals and Botanical Products · data as of November 13, 2026

$8.48Market cap $80M
Open the interactive analysis →

Fitlife Brands, Inc. (FTLF) is a healthcare company listed in the US with a market value of about $80M. In the twelve months to June 30, 2026 it had revenue of $101M and net income of $6M, a net margin of 6.2%.

Its overall Stock Analiz score is 3.2 out of 5 (average). The strongest part is financial health (5/5); the weakest is shareholder returns (0/5).

Key numbers: a P/E of 12.8, a price to free cash flow of 7.9, 5-year revenue growth of 30% a year, a 5-year average ROIC of 19%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 251% above the current price.

About Fitlife Brands

Fitlife Brands is listed in the US and classified in medicinal chemicals and botanical products. Revenue went from $19M in 2019 to $81M in 2025, growth of about 26.9% a year. It was profitable in 7 of the last 7 years in our data.

Score: 3.2 / 5

Value4/5
Future growth4/5
Track record3/5
Financial health5/5
Shareholder returns0/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%

Checks not passed

  • PEG below 1.5
  • Profit margin improving
  • 5-year EPS growth above 10% a year
  • ROE above 15%
  • Pays a dividend
  • Share count down over 3 years (buybacks)
  • 20% to 100% of free cash flow returned to shareholders
  • Dividend 3 years in a row

Valuation

P/E (TTM)12.8
Forward P/E—
P/FCF7.9
P/S0.8
P/B1.7
EV/EBITDA6.9
PEG—
Dividend yield—
FCF yield12.6%
Shareholder yield0.0%
Intrinsic value vs. price+251%

Growth and quality

Revenue growth (1 yr)26.4%
Revenue growth (5 yrs, per year)30.2%
EPS growth (5 yrs, per year)-8.3%
FCF growth (3 yrs, per year)21.4%
Net margin (5-yr avg.)13.3%
ROIC (5-yr avg.)19.3%
Profitable years (of last 10)7
Years paying a dividend1

Financials, last 7 years

Fiscal yearTTM2025202420232022202120202019
Revenue$101M$81M$64M$53M$29M$28M$22M$19M
Net income$6M$6M$9M$5M$4M$5M$9M$3M
Free cash flow$10M$7M$10M$4M$4M———
EPS (diluted)$0.62$0.63$0.91$0.54$0.00$0.56$0.97$1.16
Net margin6.2%7.8%13.9%10.1%15.4%19.4%40.6%13.4%
ROIC—15.5%20.0%12.1%20.2%28.7%28.4%74.8%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

What is Fitlife Brands’s P/E ratio?

About 12.8, based on the last twelve months of diluted earnings per share.

Is Fitlife Brands stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 251% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Fitlife Brands pay a dividend?

Not currently.

Is Fitlife Brands a good stock to buy?

We do not give buy or sell advice. Fitlife Brands scores 3.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.